Drug evaluation services

New PAH results with the Monocrotaline model

Pulmonary Arterial Hypertension (PAH) is an orphan disease, incurable that remains highly lethal despite recent advanced medical treatment. Various pharmacological therapies such as Prostacyclines, Endothelin receptor antagonists, PDE5 inhibitors have been reported for PAH diseases. In spite of these treatments, the average of survival is 2,8 years so new treatments must be developed. This growing recognition of these health problems, and their risks, increases our need for effective resea...

Animal models of Diabete?

Diabetes is a chronic metabolic disorder, caused by a failure of the body to produce insulin and/or an inability of the body to respond adequately to circulating insulin. The WHO estimates that 346 million people worldwide have diabetes. This growing recognition of these health problems, and their risks, increases our need for effective research, drug development and treatment. An essential component of developing new medicines in this therapeutic area is understanding the fundamental mechani...
Waygo : Agence webmarketing